Found 67 clinical trials
Eltrombopag for People With Fanconi Anemia
Fanconi anemia is a genetic disease. Some people with it have reduced blood cell counts. This means their bone marrow no longer works properly. These people may need blood transfusions for anemia
- 143 views
- 22 Dec, 2020
- 1 location
Eltrombopag Added to Standard Immunosuppression in Treatment-Naive Severe Aplastic Anemia
attacking the bone marrow. However, this treatment does not work in all people. Some people still have poor blood cell counts even after treatment. Eltrombopag is a drug designed to mimic a protein
- 172 views
- 22 Dec, 2020
- 1 location
Studies of Phlebotomy Therapy in Hereditary Hemochromatosis
: Phlebotomy therapy every 1 to 2 weeks, depending on iron levels Blood sample collection for blood cell counts and iron studies at every phlebotomy session Blood
- 114 views
- 25 Oct, 2022
- 1 location
Netarsudil Use After Descemtorhexis Without Endothelial Keratoplasty
-operative central endothelial cell counts. The anticipated enrollment is 25 patients.
- 0 views
- 07 Oct, 2022
- 1 location
Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study
The RECOVER study is a self-controlled case series to evaluate whether the addition of Fostemsavir (Rukobia) to a stable HIV regimen in virologically suppressed patients living with HIV who never experience optimal CD4 T-cell count recovery can result in meaningful increases in different immunologic parameters such as CD4 T-cell count, …
- 0 views
- 11 Oct, 2022
- 1 location
Probiotic Supplementation for Those Immune Non-responders With HIV-1 Infection
Gut bacterial community diversity and composition, immune recovery and activation in peripheral plasma/mucosa, plasma levels of gut damage, microbial translocation and inflammation at baseline and after 6 months of receiving intervention will be analyzed.
- 0 views
- 25 Apr, 2022
- 1 location
Compassionate Access of the Miltenyi Device for CD34+ Cell Selection
Objectives Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).
- 0 views
- 15 Jun, 2022
- 1 location
A Phase 2, Open-Label, Ascending Dose Study of KER-050 for the Treatment of Anemia in Patients With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
The purpose of this study is to evaluate the effects of KER-050 on anemia in patients with very low, low or intermediate risk MDS.
- 72 views
- 28 Oct, 2022
- 18 locations
Improve Treatment Outcomes for Tuberculosis Infection in Tertiary Care Hospitals
Early diagnosis can contribute to good treatment outcomes and isolate infection control.
- 4 views
- 11 Apr, 2022
- 4 locations
Escalation of Plerixafor for Mobilization of CD34+ Hematopoietic Progenitor Cells and Evaluation of Globin Gene Transfer in Patients With Sickle Cell Disease
The purpose of this research study is to test the safety and efficacy of a drug called Plerixafor. Plerixafor is approved by the US FDA for use in increasing blood stem cell counts before
- 34 views
- 18 Apr, 2022
- 1 location